Search research articles
Contact Us
Filters
Showing results (131-140 of 171) with videos related to
Page
of 18
Sort By:
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study
Kyaw Z Thein, Siqing Fu, Filip Janku, et al.
Investigational New Drugs
|
April 28, 2021
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study
Kyaw Zin Thein, Sarina A Piha-Paul, Apostolia Tsimberidou, et al.
Experimental Hematology & Oncology
|
December 30, 2021
Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors
Kyaw Z Thein, Sarina A Piha-Paul, Apostolia Tsimberidou, et al.
Journal of the American College of Radiology : JACR
|
November 19, 2021
ACR Appropriateness Criteria® Nontraumatic Chest Wall Pain
, Justin T Stowell, Christopher M Walker, et al.
Investigational New Drugs
|
October 27, 2021
Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study
Kyaw Zin Thein, Sarina A Piha-Paul, Apostolia Tsimberidou, et al.
Investigational New Drugs
|
September 25, 2021
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study
Kyaw Z Thein, Daniel D Karp, Apostolia Tsimberidou, et al.
Investigational New Drugs
|
February 20, 2025
Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study
Kyaw Z Thein, Daniel D Karp, Apostolia Tsimberidou, et al.
Investigational New Drugs
|
November 3, 2021
Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single‑center, multi‑arm phase Ib study
Kyaw Z Thein, Daniel D Karp, Apostolia Tsimberidou, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 13, 2022
Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial
Yufei Liu, Luyang Yao, Neda Kalhor, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 22, 2024
Artificial Intelligence Assessment of Chest Radiographs for COVID-19
Koji Sasaki, Guillermo Garcia-Manero, Masayuki Nigo, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 171) with videos related to
Sort By:
Page
of 18
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study
Kyaw Z Thein, Siqing Fu, Filip Janku, et al.
Investigational New Drugs
|
April 28, 2021
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study
Kyaw Zin Thein, Sarina A Piha-Paul, Apostolia Tsimberidou, et al.
Experimental Hematology & Oncology
|
December 30, 2021
Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors
Kyaw Z Thein, Sarina A Piha-Paul, Apostolia Tsimberidou, et al.
Journal of the American College of Radiology : JACR
|
November 19, 2021
ACR Appropriateness Criteria® Nontraumatic Chest Wall Pain
, Justin T Stowell, Christopher M Walker, et al.
Investigational New Drugs
|
October 27, 2021
Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study
Kyaw Zin Thein, Sarina A Piha-Paul, Apostolia Tsimberidou, et al.
Investigational New Drugs
|
September 25, 2021
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study
Kyaw Z Thein, Daniel D Karp, Apostolia Tsimberidou, et al.
Investigational New Drugs
|
February 20, 2025
Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study
Kyaw Z Thein, Daniel D Karp, Apostolia Tsimberidou, et al.
Investigational New Drugs
|
November 3, 2021
Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single‑center, multi‑arm phase Ib study
Kyaw Z Thein, Daniel D Karp, Apostolia Tsimberidou, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 13, 2022
Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial
Yufei Liu, Luyang Yao, Neda Kalhor, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 22, 2024
Artificial Intelligence Assessment of Chest Radiographs for COVID-19
Koji Sasaki, Guillermo Garcia-Manero, Masayuki Nigo, et al.
Page
of 18